Dual complement inhibition by CRIg/FH shows renoprotective effect in ischemia reperfusion injury Feb. 18, 2019
New phase III study of empagliflozin assesses cardio-renal outcomes in chronic kidney disease Feb. 8, 2019
Failure of AMPK caused by multiple uremic factors is a key mechanism of energy depletion in CKD Jan. 3, 2019
RSS